Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and neuroprotection

Sleep Disorders Associated with Parkinson's Disease: Role of Dopamine, Epidemiology, and Clinical Scales of Assessment

(2016) Shyamal H. Mehta et al.   CNS SPECTRUMS

Melatonin-mitochondria Interplay in Health and Disease

(2012) Dario Acuna Castroviejo et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Preclinical Biomarkers of Parkinson Disease

(2011) Yuncheng Wu et al.   ARCHIVES OF NEUROLOGY

Parkinson's Disease as a Neuroendocrine Disorder of Circadian Function: Dopamine-Melatonin Imbalance and the Visual System in the Genesis and Progression of the Degenerative Process

(2011) Gregory L. Willis   REVIEWS IN THE NEUROSCIENCES

The Mammalian Circadian Timing System: Organization and Coordination of Central and Peripheral Clocks

(2010) Charna Dibner et al.   Annual Review of Physiology

When Does Parkinson Disease Start?

(2010) Rodolfo Savica et al.   ARCHIVES OF NEUROLOGY

Potential use of melatonergic drugs in analgesia: Mechanisms of action

(2010) Venkataramanujam Srinivasan et al.   BRAIN RESEARCH BULLETIN

The relationship between actigraphically defined sleep disturbance and REM sleep behaviour disorder in Parkinson's Disease

(2010) Sharon L. Naismith et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study

(2010) Anthony Hale et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Activity—Rest Rhythm Abnormalities in Parkinson's Disease Patients are Related to Dopaminergic Therapy

(2010) Perez-Lloret Santiago et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder

(2010) Siegfried Kasper et al.   JOURNAL OF CLINICAL PSYCHIATRY

Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson’s disease

(2010) Kathleen A. Maguire-Zeiss et al.   JOURNAL OF NEURAL TRANSMISSION

Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson’s subject mitochondrial transfer

(2010) A. Raquel Esteves et al.   JOURNAL OF NEUROCHEMISTRY

Clinical prediction of Parkinson's disease: planning for the age of neuroprotection

(2010) R. B. Postuma et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Major life events and risk of Parkinson's disease

(2010) Naja Hulvej Rod et al.   MOVEMENT DISORDERS

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

(2010) D. Weintraub et al.   NEUROLOGY

Oscillation development for neurotransmitter-related genes in the mouse striatum

(2010) Yanning Cai et al.   NEUROREPORT

Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy

(2010) Kiren Ubhi et al.   NEUROREPORT

Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report

(2010) R. G. Stevens et al.   OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors

(2010) M. L. Dubocovich et al.   PHARMACOLOGICAL REVIEWS

Melatonin—A pleiotropic, orchestrating regulator molecule

(2010) Rüdiger Hardeland et al.   PROGRESS IN NEUROBIOLOGY

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

(2009) Thomas G. Beach et al.   ACTA NEUROPATHOLOGICA

Cause and consequence: Mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases

(2009) Gary E. Gibson et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia

(2009) Y. Compta et al.   BRAIN

Sleep disorders and daytime sleepiness in Parkinson’s disease

(2009) Renee Monderer et al.   Current Neurology and Neuroscience Reports

Update in the epidemiology of Parkinsonʼs disease

(2009) Alexis Elbaz et al.   CURRENT OPINION IN NEUROLOGY

Expression of clock genesPer1andBmal1in total leukocytes in health and Parkinson’s disease

(2009) Y. Cai et al.   EUROPEAN JOURNAL OF NEUROLOGY

Cybrid models of Parkinson's disease show variable mitochondrial biogenesis and genotype-respiration relationships

(2009) Paula M. Keeney et al.   EXPERIMENTAL NEUROLOGY

Melatonin and human reproduction: Shedding light on the darkness hormone

(2009) Venkatramanujam Srinivasan et al.   GYNECOLOGICAL ENDOCRINOLOGY

Mitochondrial Gene Therapy Augments Mitochondrial Physiology in a Parkinson's Disease Cell Model

(2009) Paula M. Keeney et al.   HUMAN GENE THERAPY

Safety and Subjective Sleep Effects of Ramelteon Administration in Adults and Older Adults With Chronic Primary Insomnia

(2009) Gary S. Richardson et al.   JOURNAL OF CLINICAL PSYCHIATRY

Parkinson’s disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients

(2009) Santiago Perez-Lloret et al.   JOURNAL OF NEUROLOGY

Melatonin and its brain metabolite N1-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice

(2009) Víctor Tapias et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents

(2009) Anupom Borah et al.   JOURNAL OF PINEAL RESEARCH

Long-term melatonin administration protects brain mitochondria from aging

(2009) Miguel Carretero et al.   JOURNAL OF PINEAL RESEARCH

Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines

(2009) Rüdiger Hardeland et al.   JOURNAL OF PINEAL RESEARCH

The course of depressive symptoms in early Parkinson's disease

(2009) Bernard Ravina et al.   MOVEMENT DISORDERS

Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention

(2009) Malú G. Tansey et al.   NEUROBIOLOGY OF DISEASE

Melatonin is released in the third ventricle in humans. A study in movement disorders

(2009) José Leston et al.   NEUROSCIENCE LETTERS

Pathophysiology of depression: Role of sleep and the melatonergic system

(2009) Venkataramanujan Srinivasan et al.   PSYCHIATRY RESEARCH

Relationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues

(2008) M. Kathleen Borland et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice

(2008) María I. Rodríguez et al.   EXPERIMENTAL GERONTOLOGY

Parkinson’s disease: genetic versus toxin-induced rodent models

(2008) Mügen Terzioglu et al.   FEBS Journal

Therapeutic Actions of Melatonin in Cancer: Possible Mechanisms

(2008) Venkataramanujan Srinivasan et al.   INTEGRATIVE CANCER THERAPIES

Is REM sleep Behaviour Disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease?

(2008) M.-H. Marion et al.   JOURNAL OF NEUROLOGY

Melatonin in Parkinson’s disease

(2008) C. A. M. Medeiros et al.   JOURNAL OF NEUROLOGY

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials

(2008) Shantha MW Rajaratnam et al.   LANCET

Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB

(2008) Isabelle Boileau et al.   MOVEMENT DISORDERS

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders

(2008) Berislav V. Zlokovic   NEURON